|Day Low/High||9.60 / 10.14|
|52 Wk Low/High||11.27 / 18.37|
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
After a busy Thursday, markets look forward to economic data and the Fed meeting next week. In the portfolio, we dropped a tech stock and added a healthcare name.
A record close for the Nasdaq was looking likely until a swift selloff in tech dragged the index from its heights.
A record close for the Nasdaq was looking likely on Friday, June 9, until a swift and unexpected selloff in tech dragged the index from its heights.
The FTC has worried that Fred's can't replace the competition lost by elimination of Rite Aid from the drugstore scene.
A sudden, surprising selloff in technology names pulls the S&P 500 and Nasdaq from record intraday highs set earlier in the session.
Stock futures move cautiously lower on Tuesday morning as investors await clarity on a number of events later in the week that could have geopolitical ramifications.
Fred's Inc. (NASDAQ:FRED) today reported financial results for the first quarter ended April 29, 2017.
U.S. stock futures decline and shares in Europe fall amid a weak U.S. dollar, rising political tensions in the Gulf region and electoral risks in the U.K.
You won't hear much from the Federal Reserve in the coming days as officials enter a blackout period ahead of their June meeting the following week.
Fight or flight? Analysts split over the path Walgreens will take if FTC says no.
Fred's, Inc. ("Fred's Pharmacy" or the "Company") (NASDAQ:FRED) today reported sales for the four-week fiscal month of May, which ended May 27, 2017.
Looking at the universe of stocks we cover at Dividend Channel, on 5/30/17, Fred's Inc. will trade ex-dividend, for its quarterly dividend of $0.06, payable on 6/15/17.
Fred's, Inc. (NASDAQ:FRED) today announced that its Board of Directors has declared a quarterly cash dividend of $0.
Fred's Inc. (NASDAQ: FRED) today announced that its first quarter 2017 results will be issued on the morning of Tuesday, June 6, 2017.
The drug stores chains would be free to merge if no decision comes before July 7.
David Einhorn is going all-in on General Motors.
Civil investigative demands are sent to affected parties to collect information for a possible lawsuit.
In recent trading, shares of Fred's Inc. have crossed above the average analyst 12-month target price of $16.00, changing hands for $16.11/share.
Fred's, Inc. ("Fred's Pharmacy" or the "Company") (NASDAQ:FRED) today reported sales for the four-week fiscal month of April and the first quarter of fiscal 2017, which ended April 29, 2017.
Investors in Fred's Inc. saw new options begin trading this week, for the June 16th expiration.
Fred's, Inc. ("Fred's Pharmacy" or the "Company") (NASDAQ:FRED) today announced that it has appointed Steven B.
Market rumors of an FTC lawsuit are hitting the shares of Rite Aid, Fred's and, to a lesser extent, Walgreens.
Earlier market optimism faded as Wednesday wore on and a financials rally gave way to a selloff in Dow Jones Industrial Average component IBM and energy shares.
The S&P 500 hugs the flatline on Wednesday afternoon as a selloff in crude oil prices and energy shares counters better-than-expected earnings from Morgan Stanley.
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Fred's Inc. , where a total volume of 4,577 contracts has been traded thus far today, a contract volume which is representative of approximately 457,700 underlying shares (given that every 1 contract represents 100 underlying shares).
Sycamore Partners' attempt to purchase divested dollar stores went poorly. Will the FTC believe Fred's can do better with Rite Aid spinoffs?
U.S. stock futures turn higher Thursday after the Fed commits to further monetary tightening in 2017. Investors also are anticipating the meeting between Donald Trump and Chinese leader Xi Jinping.